OKE vs TELO · P/E 15, rev $21.70B vs $86.0M cap
ONEOK Inc (OKE) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
TELO does not have a complete income-statement cache yet.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. TELO currently screens at market cap $86.0M.
Not investment advice. Open the OKE and TELO stock pages for the full models.
Not investment advice.